BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


H. Lee Moffitt Cancer Center & Research Institute 

12902 Magnolia Drive

Tampa  Florida  33612-9497  U.S.A.
Phone: 888-663-3488 Fax: n/a


View Clinical Trials from BioPharm Insight

Moffitt Cancer Center is …

  • Dedicated to one mission: to contribute to the prevention and cure of cancer.
  • A not-for-profit cancer center created by the Florida Legislature and opened on the campus of the University of South Florida in Tampa in 1986.
  • Named after H. Lee Moffitt, former Speaker of the Florida House of Representatives.
  • One of only 39 cancer center designated by the National Cancer Institute as a Comprehensive Cancer Center.
  • Ranked 13th in the U.S. News & World Report magazine’s “Best Hospitals” list of top cancer centers for 2005
  • A critical resource for the state of Florida, which ranks 2nd in the U.S. in both cancer incidence and mortality.
  • The site of the Bill & Beverly Young National Functional Genomics Center, funded by the U.S. Department of Defense.
  • A major cancer research center with scientific programs in Molecular Oncology; Drug Discovery; Immunology; Experimental Therapeutics; Health Outcomes & Behavior; and Risk Assessment, Detection & Intervention.
  • A center for translational research whose researchers and physicians are committed to improving cancer care by moving discoveries quickly from laboratory bench to patient bedside and into the community.
  • The recipient of more than $50 million annually in sponsored research awards.
  • The largest provider of blood and marrow transplants in the Southeastern U.S.
  • A major economic engine that employed 2,655 people and generated $361 million in direct output in 2005.

Moffitt Cancer Center provides …
  • Compassionate care through more than 200,000 outpatient visits and 6,000 admissions per year on site.
  • Statewide service, impacting 20 percent of cancer cases in Florida through a network of 16 hospital and practice affiliations and more than 400 oncologists.
  • Access to clinical trials – with more than 200 ongoing clinical trials encompassing new and established procedures in chemotherapy, surgery, radiation, and immunotherapy.
  • Screening and prevention services to more than 20,000 people per year, including genetic screening and counseling; smoking cessation programs; clinics for patients at high risk for cancer; mammography and other tests; and a wide array of community education and outreach programs.
  • Comprehensive training, in partnership with the University of South Florida College of Medicine, in all aspects of cancer treatment, research and prevention for medical students, post-graduate fellows, residents, and community physicians.
  • Cancer Answers to anyone with a question related to cancer prevention, early detection, diagnosis, treatment and research via 1-888-MOFFITT, a toll-free information line staffed by registered nurses.

Last Updated: 12-27-2006

 Key Statistics

Ownership: Private

Web Site: H. Lee Moffitt Cancer Center & Research Institute

 Company News
Rosetta Genomics Ltd. (ROSG) Announces Selection Of First Pilot Project Grant Under Strategic Alliance With H. Lee Moffitt Cancer Center & Research Institute 5/26/2015 10:33:47 AM
Cancer Genetics, Inc. (CGIX) Enters Into Multi-Year Research Collaboration With H. Lee Moffitt Cancer Center & Research Institute For Genomics-Based Prediction Of Side Effects Associated With Chemotherapy 5/6/2015 7:38:44 AM
Genomenext Inks Agreement With Nationwide Children’s Hospital For Genomic Sequencing Analysis 2/23/2015 12:53:22 PM
H. Lee Moffitt Cancer Center & Research Institute Announces Development Of Experimental Treatment For Myelodysplastic Syndromes, Autoimmune Diseases 11/17/2014 4:41:39 PM
Seahorse Bioscience And H. Lee Moffitt Cancer Center & Research Institute Collaborate To Develop Method For Measuring Metabolism Of 3D Microtissue 10/27/2014 1:06:10 PM
FORMA Therapeutics, Inc. And H. Lee Moffitt Cancer Center & Research Institute Establish Multiyear Epigenetics Alliance 9/23/2014 10:52:37 AM
Rosetta Genomics Ltd. (ROSG) And H. Lee Moffitt Cancer Center & Research Institute Enter Into Strategic Alliance To Develop microRNA-Based Cancer Diagnostics 9/3/2014 2:33:28 PM
Lion Biotechnologies, Inc. Enters Clinical Trial Grant Agreement With H. Lee Moffitt Cancer Center & Research Institute 7/30/2014 10:34:58 AM
Lion Biotechnologies, Inc. Announces Exclusive License Agreement With H. Lee Moffitt Cancer Center & Research Institute 7/25/2014 8:02:02 AM
Rosetta Genomics Ltd. (ROSG) And H. Lee Moffitt Cancer Center & Research Institute Enter Into Agreement To Advance Development Of microRNA-Based Cancer Diagnostic 6/9/2014 9:20:13 AM